Pathological gambling in Parkinson disease is reduced by amantadine.

Amantadine and cognitive flexibility: decision making in Parkinson’s patients with severe pathological gambling and other impulse control disorders

INTRODUCTION Dopamine replacement therapy for Parkinson's disease (PD) was recently linked to the development of impulse control disorders such as pathological gambling (PG), hypersexuality, compulsive shopping, and binge or compulsive eating. Antiglutamatergic agents including amantadine (Ama) reduce these behaviors in PD and non-PD patients. The aim of our study is to evaluate the changes in ...

Amantadine in the Treatment of Pathological Gambling: A Case Report

Despite almost a decade of intense research, effective treatment strategies for Pathological Gambling (PG) remain very challenging. This paper details a case report suggesting that the treatment of PG may benefit from the use of the non-specific glutamate blocker amantadine. The drug was well-tolerated and effective, leading to a 43-64% reduction in severity of gambling symptoms (as measured wi...

Targeting the Glutamatergic System to Treat Pathological Gambling: Current Evidence and Future Perspectives

Pathological gambling or gambling disorder has been defined by the DSM-5 as a behavioral addiction. To date, its pathophysiology is not completely understood and there is no FDA-approved treatment for gambling disorders. Glutamate is the principal excitatory neurotransmitter in the nervous system and it has been recently involved in the pathophysiology of addictive behaviors. In this paper, we ...

Pathological Gambling in Pd: Disease or Drug Related?

[Neurobiology of pathological gambling].

Approximately one third of problem gamblers in Finland suffer from pathological gambling. An essential factor affecting the genesis of pathological gambling is a dysfunction of the dopaminergic reward system. It may be associated with the pleasure arising from gambling along with the reward and expectance of reward. In Parkinsons's disease patients receiving dopaminergic medication, pathologica...